• 0
MENU
Cart Details

Wysliva Tablet

Product Informations: Wysliva Tablet

In Treatment of Dry mouth Radiation therapy to the head, face, or neck may also cause dry mouth. It can take 6 months or longer after radiation therapy ends for the salivary glands to start producing saliva again. Wysliva Tablet helps to increase the secretions of body fluids, particularly saliva and this helps to improve dry mouth due to radiation therapy. Take it as prescribed by the doctor to get the most benefit.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Wysliva Tablet may be taken with or without food, but it is better to take it at a fixed time.
Wysliva Tablet is a medicine used in the treatment of dry mouth especially in patients undergoing radiotherapy. It helps the salivary glands to produce more saliva when used for a long time as suggested by the doctor. Wysliva Tablet can be taken with or without food. Take it in the dose and duration as advised by your doctor. Take it regularly and at the same time each day to get the maximum benefit from the medicine. Continue taking the medicine even if you get better unless the doctor tells you to stop taking it. It is generally safe and does not usually cause any common side effects.
Alcohol : CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Wysliva Tablet. Please consult your doctor.

Pregnancy : SAFE IF PRESCRIBED

Wysliva Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding : CONSULT YOUR DOCTOR

Information regarding the use of Wysliva Tablet during breastfeeding is not available. Please consult your doctor.

Driving : CONSULT YOUR DOCTOR

It is not known whether Wysliva Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney : CONSULT YOUR DOCTOR

There is limited information available on the use of Wysliva Tablet in patients with kidney disease. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Wysliva Tablet in patients with liver disease. Please consult your doctor.

If you miss a dose of Wysliva Tablet, skip it and continue with your normal schedule. Do not double the dose.

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Xylitol (200mg)

Test Buy medical disposable face mask
to protect your loved ones